DOCSLIB.ORG

MSCI UK Prime Value Index (USD)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MSCI UK Prime Value Index (USD) MSCI UK Prime Value Index (USD) The MSCI UK Prime Value Index is based on MSCI UK Index, its parent index and captures large and mid-cap representation across the UK equity markets. The index is designed to represent the performance of companies with relatively low valuations and high quality characteristics. CUMULATIVE INDEX PERFORMANCE — NET RETURNS (USD) ANNUAL PERFORMANCE (%) (AUG 2006 – AUG 2021) MSCI UK MSCI United Year Prime Value Kingdom 200 MSCI UK Prime Value 2020 1.08 -10.47 MSCI United Kingdom 2019 26.15 21.05 2018 -10.75 -14.15 161.29 2017 20.22 22.30 150 147.68 2016 -10.76 -0.10 2015 -5.97 -7.56 2014 -9.73 -5.39 100 2013 27.19 20.67 2012 14.74 15.25 2011 1.60 -2.56 50 2010 10.17 8.76 2009 59.22 43.30 2008 -53.11 -48.34 0 2007 -4.91 8.36 Aug 06 Nov 07 Feb 09 May 10 Aug 11 Nov 12 Feb 14 May 15 Aug 16 Nov 17 Feb 19 May 20 Aug 21 INDEX PERFORMANCE — NET RETURNS (%) (AUG 31, 2021) FUNDAMENTALS (AUG 31, 2021) ANNUALIZED Since 1 Mo 3 Mo 1 Yr YTD 3 Yr 5 Yr 10 Yr Nov 30, 1995 Div Yld (%) P/E P/E Fwd P/BV MSCI UK Prime Value -0.25 -2.35 35.70 15.97 9.64 8.24 5.73 7.63 4.21 11.31 10.64 1.73 MSCI United Kingdom 0.85 -0.68 27.24 14.51 3.67 5.46 4.65 5.61 3.68 23.02 12.12 1.86 INDEX RISK AND RETURN CHARACTERISTICS (NOV 30, 1995 – AUG 31, 2021) ANNUALIZED STD DEV (%) 2 SHARPE RATIO 2 , 3 MAXIMUM DRAWDOWN TrackingTurnover Since Beta 1 3 Yr 5 Yr 10 Yr 3 Yr 5 Yr 10 Yr Nov 30, (%) Period YYYY-MM-DD Error (%) (%) 1995 MSCI UK Prime Value 1.03 8.76 41.68 25.36 21.11 18.38 0.44 0.42 0.36 0.36 70.53 2007-06-04—2009-03-09 MSCI United Kingdom 1.00 0.00 0.99 19.84 16.61 15.89 0.22 0.33 0.32 0.27 63.44 2007-10-31—2009-03-09 1 Last 12 months 2 Based on monthly net returns data 3 Based on ICE LIBOR 1M The MSCI UK Prime Value Index was launched on Sep 22, 2015. Data prior to the launch date is back-tested data (i.e. calculations of how the index might have performed over that time period had the index existed). There are frequently material differences between back-tested performance and actual results. Past performance -- whether actual or back-tested -- is no indication or guarantee of future performance. MSCI UK Prime Value Index (USD) | msci.com AUG 31, 2021 INDEX CHARACTERISTICS TOP 10 CONSTITUENTS MSCI UK MSCI United Index Parent Sector Prime Value Kingdom Wt. (%) Index Number of 24 86 Wt. (%) FERGUSON 5.98 1.31 Industrials Constituents BAE SYSTEMS 5.69 1.02 Industrials Weight (%) 3I GROUP 5.64 0.72 Financials Largest 5.98 7.31 PRUDENTIAL 5.30 2.19 Financials Smallest 1.54 0.17 AVIVA 5.20 0.88 Financials Average 4.17 1.16 IMPERIAL BRANDS 5.08 0.81 Cons Staples Median 4.43 0.58 BRITISH AMERICAN TOBACCO 5.07 3.30 Cons Staples KINGFISHER 4.98 0.41 Cons Discr DCC (GB) 4.74 0.34 Industrials M&G 4.56 0.30 Financials Total 52.25 11.29 FACTORS - KEY EXPOSURES THAT DRIVE RISK AND RETURN MSCI FACTOR BOX MSCI FaCS UNDERWEIGHT NEUTRAL OVERWEIGHT VALUE Relatively Inexpensive Stocks LOW SIZE Smaller Companies MOMENTUM Rising Stocks QUALITY Sound Balance Sheet Stocks YIELD Cash Flow Paid Out LOW VOLATILITY Lower Risk Stocks MSCI FaCS provides absolute factor exposures relative to a <-1.5 0 +1.5< broad global index - MSCI ACWI IMI. MSCI UK Prime Value MSCI United Kingdom Neutral factor exposure (FaCS = 0) represents MSCI ACWI IMI. SECTOR WEIGHTS 13.59% 18.96% 13.08% 2.93% 23.06% 28.38% Financials 28.38% Industrials 23.06% Consumer Discretionary 18.96% Consumer Staples 13.59% Materials 13.08% Communication Services 2.93% MSCI UK Prime Value Index (USD) | msci.com AUG 31, 2021 INDEX METHODOLOGY The MSCI Prime Value Indexes are designed to represent the performance of companies that exhibit relatively higher value exposure with high Quality scores within the parent universe of securities. The selection of value companies is made from a universe of companies that has undergone Quality screening. The relevant Parent Index would be any MSCI Regional or Country Index. For detailed methodology click here FACTOR BOX AND FaCS METHODOLOGY MSCI FaCS is a standard method (MSCI FaCS Methodology) for evaluating and reporting the Factor characteristics of equity portfolios. MSCI FaCS consists of Factor Groups (e.g. Value, Size, Momentum, Quality, Yield, and Volatility) that have been extensively documented in academic literature and validated by MSCI Research as key drivers of risk and return in equity portfolios. These Factor Groups are constructed by aggregating 16 factors (e.g. Book-to-Price, Earnings/Dividend Yields, LT Reversal, Leverage, Earnings Variability/Quality, Beta) from the latest Barra global equity factor risk model, GEMLT, designed to make fund comparisons transparent and intuitive for use. The MSCI Factor Box, which is powered by MSCI FaCS, provides a visualization designed to easily compare absolute exposures of funds/indexes and their benchmarks along 6 Factor Groups that have historically demonstrated excess market returns over the long run. ABOUT MSCI MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 45 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process. To learn more, please visit www.msci.com. The information contained herein (the "Information") may not be reproduced or redisseminated in whole or in part without prior written permission from MSCI. The Information may not be used to verify or correct other data, to create indexes, risk models, or analytics, or in connection with issuing, offering, sponsoring, managing or marketing any securities, portfolios, financial products or other investment vehicles. Historical data and analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information or MSCI index or other product or service constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy. Further, none of the Information or any MSCI index is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. The Information is provided "as is" and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. NONE OF MSCI INC. OR ANY OF ITS SUBSIDIARIES OR ITS OR THEIR DIRECT OR INDIRECT SUPPLIERS OR ANY THIRD PARTY INVOLVED IN THE MAKING OR COMPILING OF THE INFORMATION (EACH, AN "MSCI PARTY") MAKES ANY WARRANTIES OR REPRESENTATIONS AND, TO THE MAXIMUM EXTENT PERMITTED BY LAW, EACH MSCI PARTY HEREBY EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WITHOUT LIMITING ANY OF THE FOREGOING AND TO THE MAXIMUM EXTENT PERMITTED BY LAW, IN NO EVENT SHALL ANY OF THE MSCI PARTIES HAVE ANY LIABILITY REGARDING ANY OF THE INFORMATION FOR ANY DIRECT, INDIRECT, SPECIAL, PUNITIVE, CONSEQUENTIAL (INCLUDING LOST PROFITS) OR ANY OTHER DAMAGES EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited. © 2021 MSCI Inc. All rights reserved. MSCI UK Prime Value Index (USD) | msci.com.
Load more

Recommended publications
  • Ethics Agreement in Order to Avoid Any Financial Conflict
    Date: 7 .-e-•15 Iett..% 1--4 17 MEMORANDUM FOR THE RECORD SUBJECT: Ethics Agreement In order to avoid any financial conflict of interest in violation of 18 U.S.C. § 208(a) or the appearance of a financial conflict of interest as defined in the Standards of Ethical Conduct for Employees of the Executive Branch, 5 C.F.R. § 2635.502, and to adhere to the Ethics Pledge instituted by Executive Order 13770 issued on January 28, 2017, and entitled "Ethics Commitments by Executive Branch Appointees" (the Ethics Pledge), I am issuing the following statement. I understand that as an appointee I must sign the Ethics Pledge and that I will be bound by the requirements and restrictions therein even if not specifically mentioned in this or any other ethics agreement. Before beginning my covered Federal position, I resigned from my non-Federal positions with the Association of State and Territorial Health Officials (ASTHO) and the State of Georgia on July 6, 2017. Pursuant to the Ethics Pledge, I will not, for a period of two years from the date of my appointment to my covered Federal position, participate in an official capacity in any particular matter involving specific parties that is directly and substantially related to ASTHO, unless an exception applies or I am granted a waiver. I understand that this provision in the Ethics Pledge does not apply to state government entities, including the State of Georgia. Even when the two-year restriction of the Ethics Pledge does not apply, under 5 C.F.R. § 2635.502, I will not, for a period of one year from the date of my resignation from ASTHO and the State of Georgia, participate in any particular matter involving specific parties in which ASTHO or the State of Georgia is a party or represents a party, unless I am first authorized to participate, pursuant to 5 C.F.R.
    [Show full text]
  • Annual Report and Accounts 2019
    IMPERIAL BRANDS PLC BRANDS IMPERIAL ANNUAL REPORT AND ACCOUNTS 2019 ACCOUNTS AND REPORT ANNUAL ANNUAL REPORT AND ACCOUNTS 2019 OUR PURPOSE WE CAN I OWN Our purpose is to create something Everything See it, seize it, is possible, make it happen better for the world’s smokers with together we win our portfolio of high quality next generation and tobacco products. In doing so we are transforming WE SURPRISE I AM our business and strengthening New thinking, My contribution new actions, counts, think free, our sustainability and value creation. exceed what’s speak free, act possible with integrity OUR VALUES Our values express who we are and WE ENJOY I ENGAGE capture the behaviours we expect Thrive on Listen, challenge, share, make from everyone who works for us. make it fun connections The following table constitutes our Non-Financial Information Statement in compliance with Sections 414CA and 414CB of the Companies Act 2006. The information listed is incorporated by cross-reference. Additional Non-Financial Information is also available on our website www.imperialbrands.com. Policies and standards which Information necessary to understand our business Page Reporting requirement govern our approach1 and its impact, policy due diligence and outcomes reference Environmental matters • Occupational health, safety and Environmental targets 21 environmental policy and framework • Sustainable tobacco programme International management systems 21 Climate and energy 21 Reducing waste 19 Sustainable tobacco supply 20 Supporting wood sustainability
    [Show full text]
  • Imperial Tobacco Group Plc Annual Report and Accounts
    IMPERIAL TOBACCO GROUP PLC ANNUAL REPORT AND ACCOUNTS 2003 02 FINANCIAL HIGHLIGHTS 03 PERFORMANCE 05 INTERNATIONAL 06 COST FOCUS 08 BRANDS 10 ACQUISITIONS 12 CHAIRMAN’S STATEMENT 15 CHIEF EXECUTIVE’S COMMITTEE 17 OPERATING AND FINANCIAL REVIEW 30 OPERATING ENVIRONMENT 34 BOARD OF DIRECTORS 36 SHAREHOLDER INFORMATION 37 REPORT OF THE DIRECTORS 39 CORPORATE GOVERNANCE 45 DIRECTORS’ REMUNERATION REPORT 57 INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF IMPERIAL TOBACCO GROUP PLC 58 CONSOLIDATED PROFIT AND LOSS ACCOUNT 58 STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES 59 CONSOLIDATED BALANCE SHEET 60 CONSOLIDATED CASH FLOW STATEMENT 61 ACCOUNTING POLICIES 63 NOTES TO THE ACCOUNTS 96 IMPERIAL TOBACCO GROUP PLC BALANCE SHEET 97 NOTES TO THE IMPERIAL TOBACCO GROUP PLC BALANCE SHEET 99 PRINCIPAL SUBSIDIARIES Imperial Tobacco is the world’s fourth largest international tobacco company which manufactures, markets and sells a comprehensive range of cigarettes, tobaccos, rolling papers and cigars. ITG 01 The consistent application of our strategy has delivered compound annual growth in adjusted earnings per share of 18% and in dividends per share of 15% since 1997. FINANCIAL HIGHLIGHTS (In £’s million) 2003 2002 2001 2000 1999 Turnover 11,412 up 38% 8,296 5,918 5,220 4,494 Operating profit 881 up 46% 603 604 560 518 Adjusted operating profit 1 1,135 up 44% 789 619 568 518 Pre-tax profit 656 up 55% 423 494 450 400 Adjusted pre-tax profit 1 898 up 40% 642 509 458 400 Profit after tax 424 up 50% 283 355 323 287 Adjusted profit after tax 1 655 up 41% 465 370 331 287 (In pence) 2003 2002 2001 2000 1999 Basic earnings per share 58.1 up 42% 41.0 56.6 52.3 46.4 Adjusted earnings per share 1 90.0 up 32% 68.4 59.0 53.6 46.4 Diluted earnings per share 57.9 up 42% 40.8 56.2 52.0 46.1 Dividend per share 42.0 up 27% 33.0 28.8 26.4 23.0 1 Adjusted to exclude the effect of amortisation and exceptional items.
    [Show full text]
  • Current Research in Toxicology 1 (2020) 161–173
    Current Research in Toxicology 1 (2020) 161–173 Contents lists available at ScienceDirect Current Research in Toxicology journal homepage: www.elsevier.com/locate/crtox The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes ⇑ Liam Simms a, , Kathryn Rudd a, Jessica Palmer c, Lukasz Czekala a, Fan Yu a, Fiona Chapman a, Edgar Trelles Sticken b, Roman Wieczorek b, Lisa Maria Bode b, Matthew Stevenson a, Tanvir Walele a a Imperial Brands PLC, 121 Winterstoke Road, Bristol BS3 2LL, UK b Reemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Albert-EinsteinRing-7, D-22761 Hamburg, Germany c Stemina Biomarker Discovery Inc., 504 S. Rosa Rd., Madison, WI 53719, USA ARTICLE INFO ABSTRACT Keywords: devTOX quickPredict (devTOXqP) is a metabolomics biomarker‐based assay that utilises human induced E‐cigarettes pluripotent stem (iPS) cells to screen for potential early stage embryonic developmental toxicity in vitro. Developmental toxicity Developmental toxicity potential is assessed based on the assay endpoint of the alteration in the ratio of key Cigarettes unrelated biomarkers, ornithine and cystine (o/c). Nicotine This work aimed to compare the developmental toxicity potential of tobacco‐containing and tobacco‐free Human induced pluripotent stem cells non‐combustible nicotine products to cigarette smoke. Smoke and aerosol from test articles were produced In vitro reproduction assay using a Vitrocell VC10 smoke/aerosol exposure system and bubbled into phosphate buffered saline (bPBS). iPS cells were exposed to concentrations of up to 10% bPBS. Assay sensitivity was assessed through a spiking study with a known developmental toxicant, all‐trans‐retinoic acid (ATRA), in combination with cigarette smoke extract.
    [Show full text]
  • Massmutual Short Duration Bond.Xlsx
    Fund Holdings As of 6/30/2021 MassMutual Short-Duration Bond Fund Barings Prior to 5/1/2021, the Fund name was MassMutual Premier Short-Duration Bond Fund. Fund Position Market Security Name Weighting % Value Us 10yr Note (Cbt)sep21 Xcbt 20210921 23.43 44,652,500 USTREAS T-Bill Auction Ave 3 Mon 5.24 9,987,667 Avis Budget Rental Car Funding AESOP LLC 3.02% 2.80 5,340,681 Goldman Sachs Group, Inc. 4.25% 2.79 5,319,704 Fna VI LLC 1.35% 2.22 4,229,828 COLLEGE AVE STUDENT LOANS LLC 2.32% 1.79 3,409,152 Adani Ports & Special Economic Zone 3.38% 1.71 3,251,532 Tower Bersama Infrastructure Tbk Pt 4.25% 1.70 3,235,134 Citigroup Inc. 4.4% 1.64 3,128,408 Country Garden Holdings Company Limited 8% 1.62 3,080,136 STARWOOD MORTGAGE RESIDENTIAL TRUST 1.53% 1.61 3,073,822 SOFI CONSUMER LOAN PROGRAM TRUST 3.89% 1.60 3,054,751 Occidental Petroleum Corporation 5.5% 1.58 3,008,904 Li & Fung LTD 4.5% 1.55 2,952,486 Avis Budget Rental Car Funding AESOP LLC 3.15% 1.51 2,875,133 Nelnet Student Loan Trust 1.5% 1.46 2,773,573 BX COMMERCIAL MORTGAGE TRUST 2.07% 1.45 2,760,068 Petroleos Mexicanos 4.62% 1.44 2,750,387 Vale Overseas Limited 6.25% 1.41 2,691,164 CARVANA AUTO RECEIVABLES TRUST 1.5% 1.39 2,644,293 Kref 2018-FL1 Ltd / Kref 2018-FL1 LLC 1.43% 1.36 2,600,819 Bpce Sa 5.7% 1.34 2,562,527 Residential Asset Mortgage Products, Inc.
    [Show full text]
  • Annex 1: Parker Review Survey Results As at 2 November 2020
    Annex 1: Parker Review survey results as at 2 November 2020 The data included in this table is a representation of the survey results as at 2 November 2020, which were self-declared by the FTSE 100 companies. As at March 2021, a further seven FTSE 100 companies have appointed directors from a minority ethnic group, effective in the early months of this year. These companies have been identified through an * in the table below. 3 3 4 4 2 2 Company Company 1 1 (source: BoardEx) Met Not Met Did Not Submit Data Respond Not Did Met Not Met Did Not Submit Data Respond Not Did 1 Admiral Group PLC a 27 Hargreaves Lansdown PLC a 2 Anglo American PLC a 28 Hikma Pharmaceuticals PLC a 3 Antofagasta PLC a 29 HSBC Holdings PLC a InterContinental Hotels 30 a 4 AstraZeneca PLC a Group PLC 5 Avast PLC a 31 Intermediate Capital Group PLC a 6 Aveva PLC a 32 Intertek Group PLC a 7 B&M European Value Retail S.A. a 33 J Sainsbury PLC a 8 Barclays PLC a 34 Johnson Matthey PLC a 9 Barratt Developments PLC a 35 Kingfisher PLC a 10 Berkeley Group Holdings PLC a 36 Legal & General Group PLC a 11 BHP Group PLC a 37 Lloyds Banking Group PLC a 12 BP PLC a 38 Melrose Industries PLC a 13 British American Tobacco PLC a 39 Mondi PLC a 14 British Land Company PLC a 40 National Grid PLC a 15 BT Group PLC a 41 NatWest Group PLC a 16 Bunzl PLC a 42 Ocado Group PLC a 17 Burberry Group PLC a 43 Pearson PLC a 18 Coca-Cola HBC AG a 44 Pennon Group PLC a 19 Compass Group PLC a 45 Phoenix Group Holdings PLC a 20 Diageo PLC a 46 Polymetal International PLC a 21 Experian PLC a 47
    [Show full text]
  • DWS CROCI International
    Investment Portfolio as of March 31, 2021 (Unaudited) DWS CROCI® International VIP Shares Value ($) Common Stocks 96.0% Australia 9.1% Australia & New Zealand Banking Group Ltd. 84,659 1,814,028 BHP Group Ltd. 110,251 3,815,874 Commonwealth Bank of Australia 4,288 280,930 National Australia Bank Ltd. 62,344 1,234,218 Newcrest Mining Ltd. 15,865 297,603 (Cost $5,536,400) 7,442,653 Belgium 1.6% UCB SA (Cost $1,072,787) 13,795 1,312,687 Denmark 3.0% AP Moller - Maersk AS “B” 870 2,024,140 Novo Nordisk AS “B” 7,052 474,954 (Cost $1,948,110) 2,499,094 Finland 1.0% Fortum Oyj 12,738 340,652 Nokia Oyj* 121,910 486,937 (Cost $695,418) 827,589 France 14.1% Atos SE* 22,260 1,739,792 BNP Paribas SA* 53,894 3,290,488 Credit Agricole SA* 118,678 1,721,985 Engie SA* 79,187 1,127,334 Sanofi 30,370 3,003,484 Television Francaise 1* 80,739 737,194 (Cost $9,733,297) 11,620,277 Germany 8.4% Beiersdorf AG 12,876 1,355,372 Brenntag SE 13,966 1,193,987 Deutsche Boerse AG 4,043 672,742 Deutsche Post AG (Registered) 23,524 1,291,802 Fresenius Medical Care AG & Co. KGaA 7,353 542,699 Fresenius SE & Co. KGaA 10,857 484,249 HeidelbergCement AG 5,007 455,278 Merck KGaA 3,152 539,013 SAP SE 2,641 324,172 (Cost $6,246,907) 6,859,314 Hong Kong 0.7% CLP Holdings Ltd.
    [Show full text]
  • QAD CLOUD IMPERIAL TOBACCO ROI: 72% Payback: 4.8 Months
    ROI CASE STUDY P R O G R A M : ENTERPRISE APPLICATI ONS DOCUMENT NUMBER: S179 NOVEMBER 2 0 1 8 ROI: 72% Payback: 4.8 Months QAD CLOUD IMPERIAL TOBACCO ANALYST Seth Lippincott THE BOTTOM LINE Imperial Tobacco shifted its existing QAD production environment to the cloud rather than upgrading and refreshing its on-premises infrastructure, reducing its project costs by over seven million pounds. With its current environment reaching its end-of-life, Imperial Tobacco built a business case to upgrade to the latest version of QAD deployed on premises. However, by opting to lift and shift to the cloud, the company was able to extend the life of its current solution and lay the foundation for any future upgrade to the cloud. Imperial Tobacco was able to reduce its costs related to maintenance, development and technical staff, and technology hosting. ©2018 Nucleus Research Inc. | 100 State Street, Boston, MA, 02109 | +1 (617) 720-2000 | NucleusResearch.com 1 THE COMPANY Imperial Tobacco is comprised of several manufacturing subsidiaries that produce and market a range of tobacco products and accessories. With a long heritage in the tobacco industry and locations in the UK, Poland, Russia, Germany, Spain, and Australia, Imperial Tobacco makes brands that are available in markets around the world including West, JPS, Golden Virginia, Davidoff, and Gauloises Blondes. Imperial Tobacco is one of five subsidiaries of Imperial Brands, which has diversified into next generation products as well as owning a traditional tobacco portfolio. THE CHALLENGE In early 2017, Imperial Tobacco faced a dilemma about how to move forward with its global production environment.
    [Show full text]
  • Constituents & Weights
    2 FTSE Russell Publications 19 August 2021 FTSE 100 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.59 UNITED GlaxoSmithKline 3.7 UNITED RELX 1.88 UNITED KINGDOM KINGDOM KINGDOM Admiral Group 0.35 UNITED Glencore 1.97 UNITED Rentokil Initial 0.49 UNITED KINGDOM KINGDOM KINGDOM Anglo American 1.86 UNITED Halma 0.54 UNITED Rightmove 0.29 UNITED KINGDOM KINGDOM KINGDOM Antofagasta 0.26 UNITED Hargreaves Lansdown 0.32 UNITED Rio Tinto 3.41 UNITED KINGDOM KINGDOM KINGDOM Ashtead Group 1.26 UNITED Hikma Pharmaceuticals 0.22 UNITED Rolls-Royce Holdings 0.39 UNITED KINGDOM KINGDOM KINGDOM Associated British Foods 0.41 UNITED HSBC Hldgs 4.5 UNITED Royal Dutch Shell A 3.13 UNITED KINGDOM KINGDOM KINGDOM AstraZeneca 6.02 UNITED Imperial Brands 0.77 UNITED Royal Dutch Shell B 2.74 UNITED KINGDOM KINGDOM KINGDOM Auto Trader Group 0.32 UNITED Informa 0.4 UNITED Royal Mail 0.28 UNITED KINGDOM KINGDOM KINGDOM Avast 0.14 UNITED InterContinental Hotels Group 0.46 UNITED Sage Group 0.39 UNITED KINGDOM KINGDOM KINGDOM Aveva Group 0.23 UNITED Intermediate Capital Group 0.31 UNITED Sainsbury (J) 0.24 UNITED KINGDOM KINGDOM KINGDOM Aviva 0.84 UNITED International Consolidated Airlines 0.34 UNITED Schroders 0.21 UNITED KINGDOM Group KINGDOM KINGDOM B&M European Value Retail 0.27 UNITED Intertek Group 0.47 UNITED Scottish Mortgage Inv Tst 1 UNITED KINGDOM KINGDOM KINGDOM BAE Systems 0.89 UNITED ITV 0.25 UNITED Segro 0.69 UNITED KINGDOM
    [Show full text]
  • Imperial Tobacco Finance
    Prospectus Imperial Tobacco Finance PLC A9.4.1.1 (Incorporated with limited liability in England and Wales with registered number 03214426) A9.4.1.2 Imperial Tobacco Finance France SAS (A société par actions simplifiée incorporated in France) €15,000,000,000 Debt Issuance Programme Irrevocably and unconditionally guaranteed by Imperial Tobacco Group PLC A9.4.1.1 (Incorporated with limited liability in England and Wales with registered number 03236483) A9.4.1.2 This Prospectus amends, restates and supersedes the offering circular dated 21st February 2014. Any Notes issued after the date hereof under the Debt Issuance Programme described in this Prospectus (the “Programme”) are issued subject to the provisions set out herein. This Prospectus will not be effective in respect of any Notes issued under the Programme prior to the date hereof. Under the Programme, Imperial Tobacco Finance PLC (“Imperial Finance” or an “Issuer”) and Imperial Tobacco Finance France SAS A6.1 (“Imperial Finance France” or an “Issuer” and together with Imperial Finance “the Issuers”), subject to compliance with all relevant laws, regulations and directives, may from time to time issue debt securities (the “Notes”) guaranteed by Imperial Tobacco Group PLC (“Imperial Tobacco” or the “Guarantor”) and Imperial Tobacco Limited (“ITL”). Please see the Trust Deed dated 6th February 2015 (the “Trust Deed”) which is available for viewing by Noteholders as described on page 124 for further details about the Imperial Tobacco guarantee and page 98 for further details regarding the ITL guarantee. The aggregate nominal amount of Notes outstanding will not at any time exceed €15,000,000,000 (or the equivalent in other currencies).
    [Show full text]
  • Good Governance Board of Directors
    GOOD OVERVIEW GOVERNANCE Maintaining high standards of governance underpins everything we do, ensuring STRATEGY our people and operations behave responsibly. MARK WILLIAMSON Chairman PERFORMANCE DEAR SHAREHOLDER ENSURING OUR ANNUAL REPORT IS FAIR, This Corporate Governance Report details our approach to BALANCED AND UNDERSTANDABLE governance and the responsible way we run our business. A number of long-established and embedded processes In what proved to be a difficult year for the Group, strong underpin the key compliance requirement for our Annual Board oversight was vitally important. A major focus of Report to be fair, balanced and understandable. These include: this was the discussions relating to the best allocation of drafting of the Annual Report by appropriate senior resources to continue driving our strategy. These included management who monitor regulatory changes, are briefed approving our revised dividend policy, the commencement regarding the fair, balanced and understandable regulations of a share buyback programme, our asset divestment and ensure consistency throughout the report; GOVERNANCE programme and our investment in Auxly Cannabis Group Inc. extensive verification process undertaken to ensure factual accuracy and a fair presentation of our performance; We have also been focusing on Board succession, welcoming reviewing the use of adjusted measures and their Sue Clark and Jon Stanton to the Board and looking to appoint appropriateness in aiding users of our financial statements suitable successors for both myself and Alison Cooper, who to better understand our performance year-on-year; consideration and review of an advanced draft by Internal we announced in October will step down after 20 years with Audit and the Disclosure Committee to ensure accurate and the Company, the last nine of which have been as CEO.
    [Show full text]
  • International Value Fund Q3 Portfolio Holdings
    Putnam International Value Fund The fund's portfolio 3/31/21 (Unaudited) COMMON STOCKS (96.1%)(a) Shares Value Aerospace and defense (0.7%) BAE Systems PLC (United Kingdom) 137,249 $955,517 955,517 Airlines (1.2%) Qantas Airways, Ltd. (voting rights) (Australia)(NON) 437,675 1,698,172 1,698,172 Auto components (1.5%) Magna International, Inc. (Canada) 23,813 2,097,257 2,097,257 Automobiles (1.2%) Yamaha Motor Co., Ltd. (Japan) 70,500 1,742,181 1,742,181 Banks (14.7%) AIB Group PLC (Ireland)(NON) 708,124 1,861,795 Australia & New Zealand Banking Group, Ltd. (Australia) 165,820 3,561,114 BNP Paribas SA (France)(NON) 28,336 1,723,953 CaixaBank SA (Spain) 295,756 915,292 DBS Group Holdings, Ltd. (Singapore) 60,800 1,311,573 DNB ASA (Norway) 71,016 1,511,129 Hana Financial Group, Inc. (South Korea) 38,370 1,447,668 ING Groep NV (Netherlands) 362,345 4,432,786 Lloyds Banking Group PLC (United Kingdom)(NON) 1,014,265 594,752 Mizuho Financial Group, Inc. (Japan) 73,920 1,066,055 Skandinaviska Enskilda Banken AB (Sweden)(NON) 30,210 368,223 Sumitomo Mitsui Financial Group, Inc. (Japan) 67,400 2,450,864 21,245,204 Beverages (1.0%) Asahi Group Holdings, Ltd. (Japan) 33,700 1,426,966 1,426,966 Building products (1.1%) Compagnie De Saint-Gobain (France)(NON) 27,404 1,617,117 1,617,117 Capital markets (3.6%) Partners Group Holding AG (Switzerland) 1,115 1,423,906 Quilter PLC (United Kingdom) 798,526 1,759,704 UBS Group AG (Switzerland)(NON) 132,852 2,057,122 5,240,732 Chemicals (1.1%) LANXESS AG (Germany) 21,951 1,618,138 1,618,138 Construction and engineering (2.5%) Vinci SA (France) 35,382 3,624,782 3,624,782 Construction materials (1.2%) CRH PLC (Ireland) 38,290 1,794,760 1,794,760 Containers and packaging (0.8%) SIG Combibloc Group AG (Switzerland) 51,554 1,192,372 1,192,372 Diversified financial services (2.1%) Eurazeo SA (France)(NON) 20,542 1,563,415 ORIX Corp.
    [Show full text]